Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $4.61 million. The enterprise value is $15.54 million.

Market Cap	4.61M
Enterprise Value	15.54M

Important Dates

The last earnings date was Monday, May 20, 2024, after market close.

Earnings Date	May 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 22.32 million shares outstanding. The number of shares has increased by 39.20% in one year.

Shares Outstanding	22.32M
Shares Change (YoY)	+39.20%
Shares Change (QoQ)	+16.02%
Owned by Insiders (%)	20.57%
Owned by Institutions (%)	16.30%
Float	21.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.07
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	20.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio	0.29
Quick Ratio	0.22
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-83.00%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$63,242
Profits Per Employee	-$3.81M
Employee Count	12
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-134,160
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.38% in the last 52 weeks. The beta is 3.35, so Onconetix's price volatility has been higher than the market average.

Beta (1Y)	3.35
52-Week Price Change	-74.38%
50-Day Moving Average	0.15
200-Day Moving Average	0.30
Relative Strength Index (RSI)	57.74
Average Volume (30 Days)	3,799,587

Short Selling Information

The latest short interest is 107,301, so 0.48% of the outstanding shares have been sold short.

Short Interest	107,301
Short Previous Month	56,021
Short % of Shares Out	0.48%
Short % of Float	0.49%
Short Ratio (days to cover)	0.37

Income Statement

In the last 12 months, Onconetix had revenue of $758,898 and -$45.68 million in losses. Loss per share was -$2.51.

Revenue	758,898
Gross Profit	-938,165
Operating Income	-44.27M
Pretax Income	-45.82M
Net Income	-45.68M
EBITDA	-44.48M
EBIT	-44.73M
Loss Per Share	-$2.51

Full Income Statement

Balance Sheet

The company has $4.46 million in cash and $15.40 million in debt, giving a net cash position of -$10.94 million or -$0.49 per share.

Cash & Cash Equivalents	4.46M
Total Debt	15.40M
Net Cash	-10.94M
Net Cash Per Share	-$0.49
Equity / Book Value	-21.53M
Book Value Per Share	-0.96
Working Capital	-15.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.37 million and capital expenditures -$57,803, giving a free cash flow of -$14.42 million.

Operating Cash Flow	-14.37M
Capital Expenditures	-57,803
Free Cash Flow	-14.42M
FCF Per Share	-$0.65

Full Cash Flow Statement

Margins

Gross margin is -123.62%, with operating and profit margins of -5,833.24% and -6,019.47%.

Gross Margin	-123.62%
Operating Margin	-5,833.24%
Pretax Margin	-6,037.15%
Profit Margin	-6,019.47%
EBITDA Margin	-5,861.42%
EBIT Margin	-5,894.22%
FCF Margin	-1,900.76%

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.20%
Shareholder Yield	-39.20%
Earnings Yield	-991.88%
FCF Yield	-313.20%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Onconetix has an Altman Z-Score of -3.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.36
Piotroski F-Score	1